Literature DB >> 9842028

Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study.

R W Hautvast1, M J DeJongste, M J Staal, W H van Gilst, K I Lie.   

Abstract

BACKGROUND: Spinal cord stimulation is known to be a successful treatment for chronic intractable angina pectoris. Its effect may be anti-ischemic. It is uncertain if the clinical effect is partly caused by a placebo effect of surgery for implantation of a stimulator. In this study, clinical efficacy is investigated, together with a possible placebo effect. METHODS AND
RESULTS: Efficacy of spinal cord stimulation as a treatment for chronic intractable angina pectoris was studied for 6 weeks in 13 treated patients and 12 control patients with chronic angina. Assessments were exercise capacity and ischemia, daily frequency of anginal attacks and nitrate tablet consumption, and quality of life (perceived quality of life and pain). Compared with control, exercise duration (P =.03) and time to angina (P =.01) increased; anginal attacks and sublingual nitrate consumption (P =.01) and ischemic episodes on 48-hour electrocardiogram (P =.04) decreased. ST-segment depression on the exercise electrocardiogram decreased at comparable workload (P =.01). Anginal attacks and consumption of sublingual nitrates decreased (P =.01), perceived quality of life increased (P =.03), and pain decreased (P =.01).
CONCLUSIONS: Spinal cord stimulation is effective in chronic intractable angina pectoris, and its effect is exerted through anti-ischemic action. Efficacy is unlikely to be explained as a placebo effect from surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9842028     DOI: 10.1016/s0002-8703(98)70171-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  29 in total

Review 1.  Neurostimulation treatment for angina pectoris.

Authors:  S Murray; P D Collins; M A James
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 2.  [Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines].

Authors:  V Tronnier; R Baron; F Birklein; S Eckert; H Harke; D Horstkotte; P Hügler; M Hüppe; B Kniesel; C Maier; G Schütze; R Thoma; R D Treede; V Vadokas
Journal:  Schmerz       Date:  2011-09       Impact factor: 1.107

Review 3.  Applications of electrical pacing in the body.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2004-09       Impact factor: 4.129

Review 4.  Spinal cord stimulation: an update.

Authors:  Steven Falowski; Amanda Celii; Ashwini Sharan
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

5.  Analysis of failed spinal cord stimulation trials in the treatment of intractable chronic pain.

Authors:  Hyun-Dong Jang; Min-Su Kim; Chul-Hoon Chang; Sang-Woo Kim; Oh-Lyong Kim; Seong-Ho Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

6.  Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.

Authors:  Andrew Cassar; Megha Prasad; Martin Rodriguez-Porcel; Guy S Reeder; Darshak Karia; Anthony N DeMaria; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

Review 7.  Chronic coronary artery disease: diagnosis and management.

Authors:  Andrew Cassar; David R Holmes; Charanjit S Rihal; Bernard J Gersh
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

8.  Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia.

Authors:  Jeffrey L Ardell; René Cardinal; Michel Vermeulen; J Andrew Armour
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-10       Impact factor: 3.619

9.  Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials.

Authors:  Rod S Taylor; Jessica De Vries; Eric Buchser; Mike J L Dejongste
Journal:  BMC Cardiovasc Disord       Date:  2009-03-25       Impact factor: 2.298

10.  Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after all.

Authors:  Thomas W Jax; Ansgar J Peters; Ahmed A Khattab; Matthias P Heintzen; Frank-Chris Schoebel
Journal:  BMC Cardiovasc Disord       Date:  2009-08-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.